343 related articles for article (PubMed ID: 30478051)
1. Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
Sang B; Zhang YY; Guo ST; Kong LF; Cheng Q; Liu GZ; Thorne RF; Zhang XD; Jin L; Wu M
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11661-E11670. PubMed ID: 30478051
[TBL] [Abstract][Full Text] [Related]
2. Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells.
Lefevre G; Calipel A; Mouriaux F; Hecquet C; Malecaze F; Mascarelli F
Oncogene; 2003 Dec; 22(55):8813-22. PubMed ID: 14654778
[TBL] [Abstract][Full Text] [Related]
3. Complementation of defective colony-stimulating factor 1 receptor signaling and mitogenesis by Raf and v-Src.
Aziz N; Cherwinski H; McMahon M
Mol Cell Biol; 1999 Feb; 19(2):1101-15. PubMed ID: 9891045
[TBL] [Abstract][Full Text] [Related]
4. Different effects of point mutations within the B-Raf glycine-rich loop in colorectal tumors on mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase and nuclear factor kappaB pathway and cellular transformation.
Ikenoue T; Hikiba Y; Kanai F; Aragaki J; Tanaka Y; Imamura J; Imamura T; Ohta M; Ijichi H; Tateishi K; Kawakami T; Matsumura M; Kawabe T; Omata M
Cancer Res; 2004 May; 64(10):3428-35. PubMed ID: 15150094
[TBL] [Abstract][Full Text] [Related]
5. PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
[TBL] [Abstract][Full Text] [Related]
6. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
[TBL] [Abstract][Full Text] [Related]
7. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
8. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
9. cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.
Cohen JD; Tham KY; Mastrandrea NJ; Gallegos AC; Monks TJ; Lau SS
Toxicol Sci; 2011 Aug; 122(2):361-71. PubMed ID: 21693435
[TBL] [Abstract][Full Text] [Related]
10. Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT.
Mirza AM; Gysin S; Malek N; Nakayama K; Roberts JM; McMahon M
Mol Cell Biol; 2004 Dec; 24(24):10868-81. PubMed ID: 15572689
[TBL] [Abstract][Full Text] [Related]
11. The transcription factor NFAT1 induces apoptosis through cooperation with Ras/Raf/MEK/ERK pathway and upregulation of TNF-α expression.
Robbs BK; Lucena PI; Viola JP
Biochim Biophys Acta; 2013 Aug; 1833(8):2016-28. PubMed ID: 23583303
[TBL] [Abstract][Full Text] [Related]
12. c-Myc represses FOXO3a-mediated transcription of the gene encoding the p27(Kip1) cyclin dependent kinase inhibitor.
Chandramohan V; Mineva ND; Burke B; Jeay S; Wu M; Shen J; Yang W; Hann SR; Sonenshein GE
J Cell Biochem; 2008 Aug; 104(6):2091-106. PubMed ID: 18393360
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.
Li R; Zhang L; Jia L; Duan Y; Li Y; Bao L; Sha N
PLoS One; 2014; 9(6):e100893. PubMed ID: 24967732
[TBL] [Abstract][Full Text] [Related]
14. Correction for Sang et al., Dual functions for OVAAL in initiation of RAF/MEK/ERK prosurvival signals and evasion of p27-mediated cellular senescence.
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34544884
[No Abstract] [Full Text] [Related]
15. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of B-Raf/MEK/ERK signaling suppresses DR5 expression and impairs response of cancer cells to DR5-mediated apoptosis and T cell-induced killing.
Oh YT; Deng J; Yue P; Owonikoko TK; Khuri FR; Sun SY
Oncogene; 2016 Jan; 35(4):459-67. PubMed ID: 25867065
[TBL] [Abstract][Full Text] [Related]
18. Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.
Gao FH; Hu XH; Li W; Liu H; Zhang YJ; Guo ZY; Xu MH; Wang ST; Jiang B; Liu F; Zhao YZ; Fang Y; Chen FY; Wu YL
BMC Cancer; 2010 Nov; 10():610. PubMed ID: 21054888
[TBL] [Abstract][Full Text] [Related]
19. Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.
Woods D; Cherwinski H; Venetsanakos E; Bhat A; Gysin S; Humbert M; Bray PF; Saylor VL; McMahon M
Mol Cell Biol; 2001 May; 21(9):3192-205. PubMed ID: 11287623
[TBL] [Abstract][Full Text] [Related]
20. MAPK and Hippo signaling pathways crosstalk via the RAF-1/MST-2 interaction in malignant melanoma.
Feng R; Gong J; Wu L; Wang L; Zhang B; Liang G; Zheng H; Xiao H
Oncol Rep; 2017 Aug; 38(2):1199-1205. PubMed ID: 28677804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
